$VTAK Catheter Precision, Inc. Announces the Prese
Post# of 25326
(Total Views: 115)
Posted On: 02/22/2024 8:58:40 AM
$VTAK Catheter Precision, Inc. Announces the Presentation of the First Clinical Data on LockeT
https://www.accesswire.com/835665/catheter-pr...-on-locket
FORT MILL, SC / ACCESSWIRE / February 22, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US-based medical device company focused on novel electrophysiology products, announced that the clinical data from the first LockeT study will be presented at the Western Atrial Fibrillation Symposium (Western AFib). The 17th annual Western AFib conference is taking place in Park City, Utah from February 23 - 24, 2024.
Catheter Precision's CEO, David Jenkins, said, "We are very excited to have the initial LockeT clinical data available to share with physicians. This study demonstrates that LockeT is not only safe and effective in achieving hemostasis but that it provides additional benefits of cost savings and same-day hospital discharge."
The Western Afib symposium is an internationally recognized meeting focused on improving outcomes worldwide and features experts from the atrial fibrillation community. Educational sessions are led by world-renowned faculty and include topics related to advancements in diagnosing and treating atrial fibrillation and focused roundtable discussions.
https://www.accesswire.com/835665/catheter-pr...-on-locket
FORT MILL, SC / ACCESSWIRE / February 22, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US-based medical device company focused on novel electrophysiology products, announced that the clinical data from the first LockeT study will be presented at the Western Atrial Fibrillation Symposium (Western AFib). The 17th annual Western AFib conference is taking place in Park City, Utah from February 23 - 24, 2024. Catheter Precision's CEO, David Jenkins, said, "We are very excited to have the initial LockeT clinical data available to share with physicians. This study demonstrates that LockeT is not only safe and effective in achieving hemostasis but that it provides additional benefits of cost savings and same-day hospital discharge."
The Western Afib symposium is an internationally recognized meeting focused on improving outcomes worldwide and features experts from the atrial fibrillation community. Educational sessions are led by world-renowned faculty and include topics related to advancements in diagnosing and treating atrial fibrillation and focused roundtable discussions.
(0)
(0)Scroll down for more posts ▼